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Fibromyalgia is a chronic pain syndrome that is associated with maladaptive plasticity in
neural central circuits. One of the neural circuits that are involved in pain in fibromyalgia is
the primary motor cortex. We tested a combination intervention that aimed to modulate
the motor system: transcranial direct current stimulation (tDCS) of the primary motor
cortex (M1) and aerobic exercise (AE). In this phase II, sham-controlled randomized
clinical trial, 45 subjects were assigned to 1 of 3 groups: tDCS + AE, AE only, and tDCS
only. The following outcomes were assessed: intensity of pain, level of anxiety, quality
of life, mood, pressure pain threshold, and cortical plasticity, as indexed by transcranial
magnetic stimulation. There was a significant effect for the group-time interaction for
intensity of pain, demonstrating that tDCS/AE was superior to AE [F =(13, 364) 2.25,
p = 0.007] and tDCS [F =(13, 364) 2.33, p = 0.0056] alone. Post-hoc adjusted analysis
showed a difference between tDCS/AE and tDCS group after the first week of stimulation
and after 1 month intervention period (p = 0.02 and p = 0.03, respectively). Further,
after treatment there was a significant difference between groups in anxiety and mood
levels. The combination treatment effected the greatest response. The three groups had
no differences regarding responses in motor cortex plasticity, as assessed by TMS. The
combination of tDCS with aerobic exercise is superior compared with each individual
intervention (cohen’s d effect sizes> 0.55). The combination intervention had a significant
effect on pain, anxiety and mood. Based on the similar effects on cortical plasticity
outcomes, the combination intervention might have affected other neural circuits, such
as those that control the affective-emotional aspects of pain.
Trial registration: (www.ClinicalTrials.gov), identifier NTC02358902.
Keywords: transcranial direct current stimulation (tDCS), fibromyalgia, aerobic exercise, combined therapy, motor
cortex
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INTRODUCTION
Fibromyalgia is a chronic pain syndrome that is characterized by
the presence of diffuse pain throughout the body and secondary
symptoms, such as sleep disturbances and cognitive dysfunction
(Bernardy et al., 2013). The etiology of fibromyalgia is unknown,
but its onset is attributed to the continuity of painful stimuli,
triggering mechanisms of central sensitization (Cagnie et al.,
2014). These processes lead to maladaptive plastic changes in
cortical activity in various regions, including the classical areas
of the pain neuromatrix circuit and other neural circuits, such as
the primary motor cortex.
In this context, the Motor Cortex (M1) is an important area to
understand the pathophysiology and treatment of Fibromyalgia
Sindrome (FMS). A recent review noted that many studies
in other pain syndromes reported increased activation in this
region to rest and increased response to nociceptive sensory
stimuli, demonstrating its interaction with other areas of pain
modulation (Castillo Saavedra et al., 2014). Current studies are
using neuromodulation techniques to modify the excitability
of the M1 and provide relief from the symptoms of chronic
pain (Fregni et al., 2006; Valle et al., 2009; Mori et al., 2010;
Mendonca et al., 2011; DaSilva et al., 2012; Yoon et al.,
2013).
One such technique is Transcranial Direct Current
Stimulation (tDCS). tDCS promotes the modulation of
brain activity by subtly altering the excitability of the neuronal
membrane, and its prolonged and continuous application
can effect plastic modification, with activation of NMDA
receptors and the Long Term Potentiation (LTP) phenomenon
(Nitsche et al., 2003; Fritsch et al., 2010; Monte-Silva et al.,
2013).
Preliminary trials that have tested tDCS of the M1 in reducing
fibromyalgia pain have reported positive results, although the
effects varied and, in some cases, were small (Fregni et al.,
2006; Valle et al., 2009; Mendonca et al., 2011). Based on the
mechanisms of tDCS, one approach to optimizing its effects
is to combine it with a behavioral intervention that promotes
activation in the same neural circuit. Thus, we hypothesize that
tDCS of the M1, combined with aerobic exercise, would enhance
the effects of tDCS on FMS pain.
Aerobic exercise acts systemically, influencing various aspects
of body function. For example, it can affect a large neural circuit
via afferent input (bottom-up) from somatosensory stimulation
and a neuroendocrine response (Schwarz and Kindermann, 1992;
Goldfarb and Jamurtas, 1997; Kramer and Erickson, 2007).
This technique has long-lasting effects and can be sustained
by the patient to maintain the improvement (Colcombe et al.,
2004).
We tested the clinical and neurophysiological effects of
the combination of tDCS and aerobic exercise on a treadmill
over 1 month to generate results of a new intervention
and to understand how modulation of the M1 circuit leads
to pain control. Our main aim was to assess whether the
combined intervention of tDCS and aerobic exercise would
induce significantly greater pain reduction as compared to tDCS
alone and aerobic exercise alone.
METHODS
Participants
Participants were recruited through social networks, local health
care facilities, and referrals for a waiting list for treatment at
the Institute of Physical Medicine and Rehabilitation, Faculty of
Medicine, University of São Paulo, Brazil. The study population
comprised individuals who were diagnosed with fibromyalgia.
The diagnosis was performed by medical specialists taking into
consideration the modified criteria from ACR (Wolfe et al.,
2011). For the evaluations were taken into account the terms
described by the modified evaluation criteria and who fulfilled
the following eligibility criteria: (a) completed high school and
(b) age between 18 and 65 years. Subjects were excluded if
they: (a) were on medication for pain control for less than 2
months; (b) had been treated for depression for less than two
months; (c) had epilepsy, psychiatric disorders, or any recent
episode of neurological disorders, such as idiopathic syncope;
(d) were pregnant and infant-aged; (e) had metallic implants
in the brain; (f) were using illicit drugs; or (g) had been
undergoing some type of physical treatment for less than 2
months.
All patients signed informed consent forms prior to initiation
of the study procedures. This research was approved by the
research ethics committee at CONEP under registration number
CAAE 08603612.0.0000.5511. The trial was also registered at
clinicaltrials.gov (identifier NTC02358902).
Experimental Design
The design was a clinical, randomized, double-blind study with
2 months of follow-up. Data were collected from January 2013
to November 2014. Recruitment was performed during the
entire period since interventions were carried out in group each
month.
A total of 45 participants were included (Figure 1).
Randomization was performed by a blinded therapist using
sealed envelopes for each individual. The subjects were divided
into 3 intervention groups: tDCS/AE, which received active
intervention of aerobic exercise training and active tDCS
intervention; AE, which received active intervention of aerobic
exercise and placebo tDCS; and tDCS, which received placebo
AE and active intervention for tDCS.
Participants were blinded to the intervention groups, as were
the therapists who performed the evaluation.
Outcomes
All variables were measured 1 week before the beginning of the
intervention (baseline), after intervention period (T2) and during
the periods of follow-up conducted 1 month (T3) and 2 months
(T4) after the end of the intervention period. For variables such
as pain intensity and intensity of anxiety, these evaluations were
performed every day before the intervention. The assessment of
cortical excitability was conducted at baseline, T2, T3, and T4
and after the fifth day of intervention (first week) (T1), which
corresponding to the end of the stimulation period. This strategy
was chosen to minimize long periods of evaluation during the
procedure, reducing burden to subjects.
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FIGURE 1 | Research flowchart.
Primary Outcome
The Visual Numeric Scale (VNS) was used to assess the intensity
of pain, as reported by the patient. This straight 10-cm scale
is numbered from 0 to 10, in which 0 represents no pain and
10 is the most pain imaginable. Subjects were asked to mark
the number that best reflected the symptoms of pain at that
moment.
Secondary Outcomes
Anxiety Levels
Anxiety levels were measured using the VNS for anxiety (from
0 to 10). Also for this outcome, assessments was carried out
at baseline, every day before the intervention, post intervention
(T2) and follow-up periods (T3, T4).
Pressure Pain Threshold
Pressure pain threshold (PPT) was evaluated with a pressure
algometer (Wagner Instruments, USA) to establish the minimum
pressure that triggered the pain at the thenar region of the
hand and the uppermost portion of the anterior tibialis. These
areas were chosen to determine the systemic effects of the
interventions. For the statistical analysis, the average of these
values was calculated.
Quality of Live
Quality of life was assessed using the SF-36 quality of life
questionnaire for all subscales: vitality, physical functioning,
bodily pain, general health perceptions, physical role functioning,
emotional role functioning, social role functioning, and mental
health.
Mood
The Beck Depression Inventory was also used to measured
symptoms of depression.
Cortical Excitability
Cortical excitability was examined by Transcranial Magnetic
Stimulation (TMS) using a figure-of-eight magnetic stimulator
coil (BiStim2 Magstim, UK). Responses to stimuli that were
applied to the motor cortex were recorded in the adductor
muscle of the thumb of the contralateral hand. The responses
of the motor evoked potential (MEP) were amplified and
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filtered by surface electromyography (Micromed SpA, Italy). The
signals were then transferred to a personal computer for oﬄine
analysis using software for data collection (SystemPlus Evolution,
Micromed SpA, Italy).
Motor threshold, motor evoked potential, intracortical
inhibition, and intracortical facilitation were measured
(Kobayashi and Pascual-Leone, 2003). All measures were
performed at the left M1 in which the tDCS was held. Motor
threshold and motor evoked potentials were evaluated by
single-pulse TMS. Motor threshold was found using the
lowest intensity for the TMS pulse over the M1 capable to
generate a peripheral response of at least 50 microvolts of
amplitude at the electromyography. The same technique was
used to determine the MEP at 120% of the intensity found
for the motor threshold. Ten MEPs were measured at each
stage.
Intracortical inhibition (ICI) and intracortical facilitation
(ICF) were evaluated by paired-pulse technique. For ICF, a
conditional pulse with an intensity of 80% of the motor
threshold and a test pulse with the MEP intensity were used.
The interstimulus interval was 10ms for ICF. In measuring
intracortical inhibition, the same parameters for the conditional
and test stimuli and an interstimulus interval of 2ms were used.
In each individual, 15 measures of ICF and ICI each were made,
randomized between inhibition, facilitation, andMEP, totaling 45
pulses for this step.
Adverse Effects
A questionnaire on the adverse effects of tDCS was given
to evaluate the adverse effects of transcranial direct current
stimulation.
To evaluate the adverse effects of AE, we recorded any
musculoskeletal symptoms—such as pain, fatigue, tingling—
or cardiovascular symptoms—such as shortness of breath,
chest pain, exorbitant increased blood pressure—every day of
intervention.
Interventions
The treatment was administered for 4 weeks. During the first
week, the subject underwent tDCS every day (Monday to
Friday) and aerobic exercise 3 days per week (neuromodulatory
phase). On the days on which exercise was performed, the
2 techniques were executed in combination simultaneously.
In the following weeks, the subject attended to perform the
procedure on 3 days per week for aerobic exercise only
(Figures 2, 3).
FIGURE 2 | Methodology of intervention. Subjects received intervention with tDCS during the first week for five consecutive days, associated with aerobic exercise
training performed three times a week for a month.
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FIGURE 3 | Illustration of interventions in combination, tDCS/AE group
which was performed aerobic exercise in combination with tDCS.
Standard safety assessments were performed by the nursing
team before and after every visit day including heart and
respiratory rate and blood pressure.
Intervention 1: Transcranial Direct Current Stimulation
tDCS was performed using a monophasic current device (DC
stimulator, NeuroCom, Germany). Pairs of silicon sponge surface
electrodes (35 cm2) were soaked in saline and positioned as
follows: the anode was placed over the region of the primary
motor cortex (M1) per the International 10/20 system at point
C3 (M1 left), and the cathode was placed over the supraorbital
region, contralateral to the anode (right).
The treatment method entailed 5 days of stimulation with
monophasic continuous current with an intensity of 2mA for
20min. For stimulation a gradual current ramp-up and ramp-
down with 30 s duration was used.
The sham procedure for tDCS was performed with same
placement of electrodes as in the active group, but the stimulation
was administered for only the initial 30 s, with the power turned
off for the remaining period.
Intervention 2: Aerobic Exercise
Aerobic exercise was performed on a treadmill (Kikos E100,
Brazil) for a period of 30min per session. The exercise was
scheduled to start at an intensity of 60% of the maximum
Heart Rate (HR) for each patient. Maximum HR was defined
as HRmax = 208 − (0.7 ∗ age; Tanaka et al., 2001). HR
was monitored throughout the entire procedure (heart monitor,
Oregon Scientific, Brazil). After the second week, the intensity
could be increased to 70% of the maximum HR, based on the
individual’s response. At the beginning and end of the exercise,
the lower limbs were stretched in each session.
The sham procedure for AE consisted of subjects undergoing
the training on the treadmill, but HR was maintained within 5%
of the resting HR at the minimum speed on the treadmill.
Statistical Analysis
All subjects completed the intervention period and carried out
the post intervention assessment (T2). There was a loss of 12%
of the sample in the first follow-up, and a loss of 28% of the
sample in the second period of follow-up. Dropouts during
follow-up were similar across groups. Specific missing data per
group is described in Figure 1. Missing data were treated by
intention-to-treat analysis, taking into account the method of the
last observation carried forward. Sensitivity analysis was carried
out with complete cases analysis. The Kolmogorov-Smirnov test
demonstrated normal distribution of the data. Thus, parametric
tests were performed, and the data were expressed as mean and
standard deviation for the analysis and as mean and standard
error in the graphs.
To compare the effects of tDCS and aerobic exercises on
the main outcome variable—the VNS—we used mixed ANOVA,
including the main effects of time [baseline, each day before
the intervention (Days 1–13) and the follow-up period (1 and 2
months)], group (tDCS/AE, AE, and tDCS), and the interaction
group X time. Post-hoc analyses were conducted using reduced
ANCOVA models (for each time point: T1, T2, T3, and T4)
adjusted for variables indexing baseline psychiatric and pain
characteristics since these variables have an influence on final
pain symptoms.
For other outcome variables, as dependent variables in
the ANOVA models, we used the SF36 (all subscales),
Beck Depression Inventory, pressure pain threshold, and
neurophysiological parameters.
The independent fixed variables were time (baseline, post-
treatment, follow-up 1, and follow-up 2), group (tDCS/AE, AE,
and tDCS), and the group-treatment interaction. The effect size
(cohen’s d effect size) was calculated from the difference in values
between baseline and post-treatment comparing the combination
group with the other groups.
A similar analysis was conducted for the secondary outcomes.
The predictors of outcome were analyzed by linear regression
using univariate models, with the difference in pain intensity
before and after the intervention as the dependent variable and
age, time of pain, VNS values at baseline, SF36 (all subscales),
Beck Depression Inventory, and changes in neurophysiological
parameters at the post-treatment evaluation as independent
variables. A p < 0.05 indicated a statistically significant result.
The data were organized and tabulated using Stata 12.
RESULTS
Of the study participants, 44 were female. Considering the total
sample all were right-handed, with a mean age of 47.4 (±12.1),
and mean duration of pain of 138.5 (±94.2) months. Other
demographic data are available in Table 1. Forty five individuals
completed the intervention period. For the follow-up period
there were three losses in group tDCS/AE, four losses in group
AE, and six losses in group tDCS (Figure 1).
Primary Outcome: Visual Numeric Scale
Pain intensity had a significantly effect on interaction time vs.
group [F(26, 546) = 2.08, p = 0.0015]. Similarly, there were
significant main effects of group [F(13, 546) = 6.78, p < 0.001]
and time [F(2, 546) = 32.16, p < 0.001]. By post-hoc analysis,
there was a difference between the tDCS/AE and AE groups
[F(13, 364) = 2.25, p = 0.007] and the tDCS/AE and tDCS
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TABLE 1 | Sample data at baseline.
tDCS + AE AE tDCS p-value*
Age (years) (±SD) 44.5 (±14) 48 (±11.8) 49.9 (±10.6) 0.4
Gender (F/M) 14/1 15/0 15/0
Regular exercises (Y/ N) 2/13 4/11 3/12
Pain duration (months) (±SD) 140.6 (±72.2) 149.3 (±111.1) 125.6 (±100.2) 0.7
Hours of sleep (±SD) 5.3 (±1.5) 5.8 (±1.5) 5.7 (±1.8) 0.7
VNS (±SD) 7.3 (±1.7) 6.8 (±2.0) 7.2 (±1.2) 0.72
*Data are presented as mean and standard deviation. Analyzes performed by one way ANOVA.
FIGURE 4 | Response of pain intensity (VNS pain). T1, assessment after
the fifth day of intervention; T2, assessment after 1 month of intervention; T3,
assessment after 1 month of the end of the intervention (follow-up 1); T4,
assessment after 2 months of the end of the intervention (follow-up 2). Data
presented as mean and standard error. *Statistical analysis demonstrated
significant result for T1 (p = 0.02) and at T2 (p = 0.03) between tDCS/AE
group and tDCS group.
groups [F(13, 364) = 2.33, p = 0.0056]. Analysis using covariate
adjustment—with baseline psychiatric (anxiety level and mental
health—SF-36) and pain characteristics—showed that there are
significant changes at day 5 (end of stimulation—T1) and at
the end of the protocol (T2) (p = 0.029 and p = 0.030,
respectively), but not at the two follow-ups (p > 0.5 for both
analyses) (T3 and T4) (Figure 4). Values of mean, standard
deviation and percentage of improvement are described in
Table 2.
Subsequent analysis using covariate adjustments
demonstrated a difference between the groups tDCS/AE
and tDCS at the end of the first week of intervention (effect
size = 0.6, p = 0.02) and at the end of the 1 month intervention
(effect size = 0.56, p = 0.03). For the comparison between the
groups tDCS/AE and AE, although effect sizes were also large,
there was no significant differences at day 5 (effect size = 0.68,
p = 0.14) and, at the end of the 1 month intervention, although
p-value was less than 0.1, it did not reach significance (effect
size = 0.59, p = 0.08). The comparisons between the groups
AE and tDCS revealed no significant differences (p > 0.5 for
the comparisons between day 5 and end of 1 month). In fact the
TABLE 2 | Mean and standard deviation values of primary outcome
(VNS-pain).
tDCS/AE group AE group tDCS group
BASELINE
Mean (±SD) 7.3 (±1.75) 6.8 (±2.0) 7.2 (±1.27)
T1
Mean (±SD)
% of improvement from baseline
4.4 (±2.85)
39.7%
5.2 (±2.25)
23.5%
5.9 (±1.27)
18%
T2
Mean (±SD)
% of improvement from baseline
4.5 (±2.29)
38.3%
5.2 (±1.83)
23.5%
5.7 (±2.31)
20.8%
T3
Mean (±SD)
% of improvement from baseline
5.6 (±2.31)
23.2%
5.3 (±2.32)
22.0%
5.5 (±1.91)
23.6%
T4
Mean (±SD)
% of improvement from baseline
5.0 (±2.4)
31.5%
5.5 (±2.45)
19.1%
5.7 (±2.38)
20.8%
effect sizes comparing these two groups were very small (effect
size day 5= 0.12 and effect size at end of month= 0.07).
Sensitivity analysis demonstrated no difference in statistical
results.
Secondary Outcomes
Anxiety Level
Anxiety level showed a significant result for the time-group
interaction [F(8, 168) = 3.86 p< 0.001] and time [F(4, 168) = 11.70,
p < 0.001] but not for group [F(42, 168) = 7.17, p = 0.09;
Figure 5).
Pressure Pain Threshold
With regard to pressure pain threshold, the time-group
interaction was not significant [ANOVA, F(9, 126) = 2.78, p =
0.08]. but because the p-value of this interaction was less than
0.1, we also calculated the main effects and found that group
[F(3, 126) = 4.44, p = 0.005] and time [F(2, 126) = 77.87, p <
0.001] were significant. The results are shown in Figure 6.
Quality of Life: SF-36
For the vitality, physical functioning, bodily pain, physical role
functioning, emotional role functioning, social role functioning,
and mental health subscales, no significant differences for the
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FIGURE 5 | Response for level of anxiety (VNS anxiety). T1, assessment
after the fifth day of intervention; T2, assessment after 1 month of intervention;
T3, assessment after 1 month of the end of the intervention (follow-up 1); T4,
assessment after 2 months of the end of the intervention (follow-up 2). Paired
evaluation between groups p < 0.001. Data presented as mean and standard
error.
FIGURE 6 | Data for pressure pain threshold. Group tDCS/AE
demonstrating a relative of the pressure pain threshold increased, maintained
during periods of follow-up. Group AE slight increase after the intervention,
apparently not maintained at follow-up period. tDCS group with mild increase
in the pressure pain threshold, being held in the follow-up period. No statistical
significant data were observed. Data shown as mean and standard error.
main interaction between time and group were observed (p >
0.05 for all). The data on the mean and standard deviations are
listed in Table 3.
For the general heath perceptions subscale, there was a
significant result for the time-group interaction [F(6, 84) = 3.9,
p = 0.001] and for group [F(3, 4) = 7.4, p = 0.004], but no
significant differences were noted in the effect of time [F(2, 2) =
0.6, p = 0.549]. By post hoc analysis, there was a difference before
the intervention for the combination group vs. the AE and tDCS
groups (p = 0.003 and p = 0.012, respectively) at the end of TA
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intervention (T2) (AE vs. tDCS p = 0.009) and at follow-up 2
(T4) (tDCS/AE vs. tDCS p = 0.006).
Mood
The evaluation of Beck Depression Inventory scores
demonstrated no statistical significance for the interaction
of time and group [F(6, 123) = 0.84, p = 0.54], but group
[F(2, 123) = 8.55, p < 0.001] and time [F(3, 123) = 18,26,
p < 0.001] had significant effects. In an exploratory analysis
of this variable, removing the follow-up periods to better
understand the immediate effects of the interventions, significant
results were found for the time-group interaction [F(2, 41)
= 3.22, p = 0.05], group [F(2, 41) = 6.22, p = 0.004], and
time [F(1, 41) = 37.33, p < 0.00]—the combined intervention
group experienced the largest decrease in depression intensity
(p = 0.001) vs. the AE group at the end of the intervention
period (T2). Data of mean and standard deviation described in
Table 2.
Neurophysiological Data
With regard to TMS parameters, there were no significant results
for the main analysis of time vs. group for MEP [F(8, 128) = 0.57,
p = 0.8], or time [F(2, 168) = 2.34, p = 0.057], and group had a
significant effect [F(2, 168) = 5.37, p = 0.005]. These results were
similar to those of the other TMS variables. There were no effect
of the interaction of time and group for ICF [F(8, 128) = 0.56,
p = 0.8] and for the interaction effect of ICI [F(12, 128) = 1.6,
p = 0.9]. The data for this variable are shown in Figure 7.
Regression Analysis
To better understand the influence of demographic, clinical
outcomes, and also the baseline pain status on the pain response
to the interventions, we initially ran univariate regressionmodels,
considering the difference between pain scores before and
after the treatment as the dependent variable. The independent
variables were the baseline values of the following: duration of
pain, intensity of pain, anxiety, pain threshold,mood, subscales of
quality of life, and cortical excitability values (MEP, ICI, and ICF),
and also intervention group (type of intervention). We defined
significance as p < 0.01 for this initial analysis. A relationship
was observed between the response in pain intensity (difference
between pain scores before and after treatment) and baseline pain
intensity values (p = 0.01) and baseline anxiety levels (p = 0.01).
The regression data are shown in Table 4. Correlation analysis
were also carried out for those variables. Results are shown in
Table 1, at Supplementary Material.
We then performed multivariate regression analysis, with
the difference in pain intensity as the dependent variable and
baseline pain level, anxiety and mood scores, and the respective
interactions as the independent variables.
The multivariate model with mood and baseline pain levels
showed significant results (model p = 0.0003). Baseline pain
correlated positively with changes in pain after treatment (b =
0.53 and p = 0.002) and mood scores (b = 0.07 and p = 0.006),
indicating that higher pain and depression scores at baseline
were associated with a greater pain response. Baseline pain scores
appeared tomodify the effect of depression on the response to the
FIGURE 7 | Data for cortical excitability. (A) Data for motor evoked potential (MEP). There was an increased excitability in the tDCS/AE group until the end of the
intervention, not being maintained after the period of follow-up. For tDCS group there was an increase in cortical excitability after just 1 week period of intervention that
occurred with active stimulation. The EA group showed a slight decrease in MEP after the intervention. (B) Intracortical facilitation. There was a slight decrease in
intracortical facilitation, represented by decreased amplitude of MEP’s only in group tDCS/AE. (C) Intracortical inhibition. There was an increase in intracortical
inhibition during the protocol period for tDCS/AE group, and in the follow-up periods an increase above the baseline. No statistically significant findings were
observed. Data shown as mean and standard error.
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interventions, indicating that the association between depression
and the response to the interventions weakened with a decrease
in baseline pain values (Table 5).
Adverse Effects
All adverse effects weremild and did not differ between treatment
groups (Table 6).
DISCUSSION
This study has demonstrated that neuromodulation with tDCS,
in association with aerobic exercise training, in fibromyalgia
patients effects greater decreases in pain intensity than the
individual techniques. Anxiety levels also improved in the
combination therapy group. There was a marginal but significant
increase in pain threshold in the combination group compared
with tDCS alone. The results for depression were better in
the tDCS/AE group vs. the other 2 groups, but did not
show significant results in statistic. No significant differences
in cortical excitability were observed. Baseline pain and mood
scores appeared to be related to the response to these
treatments.
The main hypothesis of this study is that the combination
of techniques has greater effects in pain intensity in patients
TABLE 4 | Results for univariate linear regression models.
P-value B Coefficient
Age 0.9 0.001
Intervention Group 0.09 −0.63
Pain duration 0.6 0.001
PPT 0.7 0.07
MEP 0.6 0.14
ICF 0.5 0.12
ICI PRE 0.1 0.79
SF36 Physical functioning 0.9 0.002
SF36 Physical role functioning 0.4 −0.008
SF36 Bodily pain 0.8 −0.006
SF36 General health Perceptions 0.6 −0.009
SF36Vitality 0.2 −0.02
SF36 Social role functioning 0.3 0.01
SF36 Emotional role functioning 0.5 −0.004
BDI 0.4 0.022
VNS Pain baseline 0.01 0.44
VNS Anxiety baseline 0.01 0.24
with fibromyalgia. Previous studies in neuromodulation for
fibromyalgia and aerobic exercise have shown that these
techniques yield significant results compared with control
interventions and baseline symptoms (Marlow et al., 2013;
García-Hermoso et al., 2014; O’Connell et al., 2014; Vural et al.,
2014). It is important to underscore that a previous review
study concludes that there are no positive results for tDCS when
considering the aggregate results for different types of chronic
pain, particularly in the long term effects (O’Connell et al., 2014).
However in this study we chose to evaluate if there is an additive
effect when using two modulating techniques.
In this study, the effect of the combination of techniques was
compared between two active techniques and the combination
of each individual active intervention and the associated placebo
method. Although some of the results for the secondary
outcomes were marginally significant, this trial was not powered
for the secondary outcomes; also, we compared the combined
treatment against each group using one active treatment alone.
Aerobic exercise acts systemically in the body, influencing
many domains. For instance, it can alter brain activity
through motor cortex activation and neurotransmitter release
(Meeusen and De Meirleir, 1995). This concept is known as
exercise-induced hypoalgesia, which is regulated by the release
of endogenous opioids (Koltyn, 2000). In addition, exercise
modifies the activity in certain regions in the cortex through
facilitatory and learning mechanisms, leading to long-term
potentiation (LTP) mechanisms (Erickson and Kramer, 2009;
TABLE 6 | Side effects occurrence
tDCS/AE AE tDCS Total P-value*
AEROBIC EXERCISE
Mild Muscle Pain 4 3 0 7 0.1
tDCS
Headache 3 4 3 10 1.0
Neck Pain 1 2 1 4 1.0
Skull Pain 0 0 0 0 -
Skin Injury 0 0 0 0 -
Tingling 3 4 5 12 0.91
Skin Redness 13 7 11 31 0.1
Somnolence 4 3 5 12 0.91
Concentration Issues 1 0 1 2 1.0
Mood changes 0 0 0 0 -
*Statistics was performed by fisher exact test.
TABLE 5 | Pain intensity data stratified by level of depression.
tDCS/AE group AE group tDCS group
BDI VNS %* BDI VNS %* BDI VNS %*
No depression or mild depression 11.8 6.0 26 9.1 6.3 31 11.5 6.3 22
Moderate to severe depression 25.7 7.9 37 29.3 7.2 24 29.9 7.4 20
*Percentage of improvement from the mean values. BDI, Beck depression inventory. VNS, Visual numeric scale.
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Lojovich, 2010). Various studies have reported beneficial results
of exercise in many chronic pain syndromes (Nijs et al., 2012).
However, the results are somewhat mixed. Patients with
widespread pain experience immediate worsening of symptoms
due to dysfunction in endogenous analgesia mechanisms, which
might be related to myofibril injury, which causes inflammation
and increased nociceptive signaling. Therefore, its use is
somewhat limited. To obtain beneficial results it is necessary
to overcome this phase, which is not achieved by a majority of
patients.
Another method of influencing the motor system is
neuromodulation with tDCS (Mendonca et al., 2011). The basic
mechanism of action of tDCS is modulation of spontaneous
neuronal firing through induced polarization of neural tissue.
In this context, anodal tDCS leads to depolarization and thus
an increase in spontaneous neuronal firing; cathodal tDCS
has the opposite effects. tDCS effects motor cortex activation
(M1), resulting in secondary modulation of regions that are
associated with pain modulation (Castillo Saavedra et al.,
2014).
Continued use of tDCS induces plastic changes and can lead
to pain relief for 1 month after the end of the intervention (Fregni
et al., 2006). Several studies have shown that five consecutive
applications of tDCS over the M1 relieve pain and improve
quality of life and sleep in various chronic pain syndromes
(Fregni et al., 2006; Roizenblatt et al., 2007; Valle et al., 2009).
Based on the effects of aerobic exercise and the mechanisms
of tDCS, we hypothesized that the combined therapy would be
more effective than each method alone, because tDCS would
prime the system, which would be subsequently modified by
aerobic exercise. Another possibility is that these techniques have
disparate neural targets and thus do not synergize. Our data
on the neurophysiological assessment with TMS, demonstrating
no changes in cortical plasticity of the motor cortex between
the interventions, supporting that the additional effects of the
combination therapy are related to the activity in other neural
circuits, independent of the motor system.
Other protocols that have testing the combination of tDCS
with other techniques have been reported. Riberto et al. (2011)
developed a regimen, comprising tDCS and a multidisciplinary
rehabilitation program, observing improvement in only one
variable in the SF-36 questionnaire for quality of life (pain
domain only). The authors implemented an exercise program,
which used stretching and ergonomic and posture instructions 3
times per week, and performed tDCS once per week for 10 weeks.
The difference in the use of tDCS might explain the differing
results comparing to our results—achieving long-term effects
requires a protocol with more days of stimulation in a shorter
time (Nitsche et al., 2008).
Another study (Boggio et al., 2009) showed that a single
application of tDCS, associated with the use of peripheral
TENS, for the treatment of chronic pain had a superior effect
compared with tDCS or TENS alone. For other areas, such as
cognitive and motor rehabilitation, several trials have combined
tDCS with various training methods, including robotics, virtual
reality, and computer-based training (Soler et al., 2010; Giacobbe
et al., 2013; Martin et al., 2014), the results of which support
combination treatment to enhance and guide the effects of
tDCS.
We evaluated cortical excitability using single-pulse and
paired-pulse TMS to assess motor cortex plasticity changes that
were associated with these three groups of treatments. A previous
study demonstrated that FM subjects experience alterations in
these parameters, such as increased MEPs at rest and reduced
ICI and ICF (Salerno et al., 2000; Mhalla et al., 2010). Although,
our results were marginally significant, we noted an overall
increase in MEP, a decline in ICI, and small changes in ICF.
But, we did not observe any significant differences between
groups. In contrast, Antal et al. (2010) observed a reduction in
ICI after anodal stimulation, but they used different stimulation
parameters (smaller electrode size and intensity of 1mA). In
a study using repetitive TMS (rTMS) using 10Hz of intensity,
which also activates the motor cortex, the authors demonstrated
an increase in ICI in accordance to our results (Lefaucheur
et al., 2006; Dall’Agnol et al., 2014). The lack of difference
between groups but the disparate behavioral results suggest
that the differential results are attributed to nonmotor neural
circuits.
Notably, the initial level of pain and mood appears to be a
predictor of outcome. We observed that individuals with higher
pain levels and higher levels of depression responded better to
the treatment, indicating greater central sensitization that might
be responsive to the combined intervention; however the results
of the prediction model need to be interpreted carefully given the
relatively small sample size for this analysis.
A limitation of this research is related to blinding. There is
a debate on the effectiveness of blinding in tDCS studies. Some
studies such as the one from Villamar et al. (2013) shows that
blinding in single session cross-over studies is not adequate.
However, further studies such as the one from Brunoni et al.
(2014) showed that blinding in clinical trials in which the
treatment effect plays a major role, such as the blinding method
of tDCS is comparable to drugs such as sertraline (Brunoni
et al., 2014). Regardless we did not conduct blinding assessment
given the questionable results of this assessment as patients may
correlate stimulation condition with improvement. Finally, we
observed that there were no significant differences in adverse
effects of tDCS, not even when with regard of skin redness
(86% of individuals in the tDCS/AE group, 47% of individuals
in the EA group, 73% of individuals in the tDCS group,
without significant results p = 0.1) shown in Table 4. There
were also no differences in adverse effects of aerobic exercise.
In addition, all groups received two forms of intervention
associated, with one active intervention at least which may
have also helped to maintain blinding of the other intervention.
Another limitation is related to loss of follow-up. Although this
is a potential source of bias, missing data were completely at
random and distributed equally across groups of treatment. Also
it is important to highlight that all patients completed the entire
month of intervention and the subsequent final evaluation. In
addition, sensitivity analysis showed no significant differences in
the results.
Based on these findings, the three groups showed positive
effects in many variables, such as pain relief, quality of life,
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depression, and anxiety, but there was a larger effect that was
associated with the combination treatment. The simultaneous
effect of the combination treatment on pain and depression levels
in fibromyalgia should prompt larger trials on the effects of this
modality with longer follow-up periods.
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